Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
Donn Casale becomes ARS Pharmaceuticals (SPRY) CEO and joins board through 2029 - Stock Titan
Google News – Pharmaceuticals External News
Crinetics Pharmaceuticals (CRNX) Agreed To A $10 Billion All Cash Sale To Vertex - simplywall.st
Google News – Pharmaceuticals External News
Pangea Pharmaceuticals Advances Its Next Phase of Growth With an Expanding Commercial Portfolio - Business Wire
Google News – Pharmaceuticals External News
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Google News – Pharmaceuticals External News
ARS Pharmaceuticals taps Donn Casale as CEO after Lowenthal exit - Stock Titan
Google News – Pharmaceuticals External News
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers - Yahoo Finance
Google News – Pharmaceuticals External News
The Changing Reality of Pharmaceutical Commercialization | PharmExec - Pharmaceutical Executive
Google News – Pharmaceuticals External News
Biocryst Pharmaceuticals stock hits 52-week high at 10.94 USD - Investing.com
Google News – Pharmaceuticals External News
Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S - PR Newswire
Google News – Pharmaceuticals External News
Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related) - Yahoo Finance
Google News – Pharmaceuticals External News
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion - Pharmaceutical Executive
Google News – Pharmaceuticals External News
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Google News – Pharmaceuticals External News
Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms - The Boston Globe
Google News – Pharmaceuticals External News

